Cargando…
New Considerations in the Design of Clinical Trials for Bone Metastases
Palliative radiotherapy (RT) is prescribed to patients with bone metastases to alleviate symptoms and improve quality of life. The lack of consistent endpoints for such trials has made cross study comparison difficult and has led to contradictory conclusions. The International Bone Metastases Consen...
Autores principales: | Lemke, Madeline, Lien, Karen, Zeng, Liang, Popovic, Marko, Zhou, Michelle, Digiovanni, Julia, Chen, Emily, Chow, Edward |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5649829/ https://www.ncbi.nlm.nih.gov/pubmed/29147271 http://dx.doi.org/10.4021/wjon445w |
Ejemplares similares
-
Skeletal morbidity rates over time in patients with bone metastases from solid tumors reported in bone modifying agents randomised trials
por: Poon, Michael, et al.
Publicado: (2012) -
A definition of “uncomplicated bone metastases” based on previous bone metastases radiation trials comparing single-fraction and multi-fraction radiation therapy
por: Cheon, Paul M., et al.
Publicado: (2015) -
Quality of life after palliative radiotherapy in bone metastases: A literature review
por: McDonald, Rachel, et al.
Publicado: (2014) -
Quality of life measurement in bone metastases: A literature review
por: Tharmalingam, Sukirtha, et al.
Publicado: (2008) -
The failures and challenges of bone metastases research in radiation oncology
por: Bedard, Gillian, et al.
Publicado: (2013)